For those of you familiar with Mark Senak, you’ll know he’s a lawyer with Fleishman-Hillard who authors the EyeOnFDA blog (also on Twitter: @eyeonfda) — a very informative and insightful blog that I subscribe to and really enjoy reading.

Check out his interview with Doug Simon (from DSSimonVlogViews) where he talks about the “state of social media in pharma” and gives some good examples of how and what pharma can do with social media, including a healthy discussion around Pharma’s use of YouTube.